News

Following the acquisition, the joint ventures will be completely owned by Biogen and will be named as Biogen Idec Italia and Biogen Idec Switzerland. The joint venture collaboration

The Veeva CRM suite consists of VBioPharma, VMobile, and VInsights, iRep for closed loop marketing on the iPad. Veeva CRM improves user adoption and sales effectiveness, while reducing

Initially, BARDA will give $38.5m to GSK over two years to develop GSK2251052, an investigational antibiotic against bacterial enzyme leucyl tRNA synthetase. The funding is expected to support

The trial aims to compare the safety and efficacy of masitinib at 6mg/kg/day with placebo in patients with primary progressive multiple sclerosis or relapse free secondary progressive multiple

With this revised deal, Anacor has decided to give an option to GSK for extending its rights for the bacterial enzyme targeting LeuRS, as well as to add

As per the revised deal, both the parties have decided to widen the development obligation milestone for the initiation of patient dosing in a phase III pivotal trial

The tie up allows Hemispherx to manufacture and supply Alferon N Injection to physicians and patients by using Armada’s national network of specialty pharmacies. Additionally, BioRidge Pharma (BRP)

In his career, he has founded three companies, two of which went public and a third that was sold to a healthcare products company. Saloff was the co-founder

The new patent entitled, ‘Neurotherapeutic treatment for sexual dysfunction,’ includes a method to treat erectile dysfunction and premature ejaculation in males, as well as enhancing libido in females.